Zepbound Prescribing Practices

Order byBest matchMost fresh

Zepbound beats Wegovy for weight loss

Zepbound trims more belly fat than Wegovy, study shows

The impact on waistlines is crucial because they are a surrogate measure for the dangerous fat that gets stored around organs in the abdomen.

· 2d · on MSN

Zepbound beats Wegovy for weight loss in first head-to-head trial of blockbuster drugs

· 2d

Zepbound Outperforms Wegovy in Head-to-Head Weight Loss Study

· 2d

This Drug Is Nearly 50 Percent More Effective Than Wegovy

While tirzepatide won out in what Aronne said many view as “a drag race of efficacy,” both are important tools for treating obesity, which affects about 40% of American adults.

· 2d

Eli Lilly's Zepbound beat Novo Nordisk’s Wegovy in a big weight loss drug study

EconoTimes · 2d

Eli Lilly’s Zepbound Outperforms Wegovy in Weight Loss Head-to-Head Trial

The New York Times3d

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight ... pharmacy benefit managers and how their business practices impact patients. Tens of thousands of Americans will ...

13d

CVS Health Excludes Zepbound: Why Eli Lilly's 11%+ Drop Looks Overdone

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.